| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |